RealTime

RealTime Manage the research and business of clinical trials, together.

Operate your clinical research site, site network, AMC, CRO, or sponsor data with intuitive software systems and unmatched customer service. Solve your research challenges with RealTimeโ€™s complete Site Operations Management System (SOMS) for clinical research Sites, Sponsors, and CROs.

06/19/2026

A test worth running before your next leadership meeting. Pick one operational question you don't get asked every day.

"Which of our sites has the slowest feasibility response time this quarter?"
"Which studies are most at risk of missing activation targets right now?"
"What's our average contract turnaround by sponsor type?"

Now time how long it takes your team to produce a reliable answer.

If the answer comes back in minutes, your visibility infrastructure is working.

If the answer requires pulling from three systems, chasing updates from two site directors, and a follow-up email to someone who built the tracking sheet, you have a different kind of problem than you probably think you do.

It's not a process problem. It's a data infrastructure problem. And most organizations don't realize the difference until a sponsor or executive asks the wrong question at the wrong time.

We built this test into our recent survey of clinical research professionals. What came back was clarifying.

Full findings here: https://realtime-eclinical.com/2026/06/05/realtime-reports-trial-start-up-visibility-performance-benchmarks-survey-summary/

If you're leading site operations, it's worth a read.

๐๐š๐ฉ๐ž๐ซ ๐ฌ๐จ๐ฎ๐ซ๐œ๐ž ๐๐จ๐œ๐ฎ๐ฆ๐ž๐ง๐ญ๐ฌ ๐š๐ฌ ๐š ๐ฌ๐œ๐š๐ฅ๐ข๐ง๐  ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ: 2/10. ๐‡๐ž๐ซ๐ž'๐ฌ ๐ฐ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ฌ๐ข๐ญ๐ž ๐ง๐ž๐ญ๐ฐ๐จ๐ซ๐ค๐ฌ ๐ซ๐ž๐ฉ๐ฅ๐š๐œ๐ž๐ ๐ข๐ญ ๐ฐ๐ข๐ญ๐ก.Site n...
06/18/2026

๐๐š๐ฉ๐ž๐ซ ๐ฌ๐จ๐ฎ๐ซ๐œ๐ž ๐๐จ๐œ๐ฎ๐ฆ๐ž๐ง๐ญ๐ฌ ๐š๐ฌ ๐š ๐ฌ๐œ๐š๐ฅ๐ข๐ง๐  ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ: 2/10. ๐‡๐ž๐ซ๐ž'๐ฌ ๐ฐ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ฌ๐ข๐ญ๐ž ๐ง๐ž๐ญ๐ฐ๐จ๐ซ๐ค๐ฌ ๐ซ๐ž๐ฉ๐ฅ๐š๐œ๐ž๐ ๐ข๐ญ ๐ฐ๐ข๐ญ๐ก.

Site networks have spent years investing in recruitment, start-up processes, and regulatory workflows. Yet one of the most important workflows in clinical research often remains surprisingly manual: source data capture.

The result?

More administrative burden.
More monitoring friction.
More protocol deviations.
Less coordinator capacity.

๐“๐ก๐ž ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐ข๐ญ๐ž ๐๐ฅ๐š๐ฒ๐›๐จ๐จ๐ค ๐•๐จ๐ฅ.3 explores why eSource is increasingly becoming the operational foundation for scalable site networks.

When data is captured consistently, monitored remotely, and standardized across locations, sites gain something every network leader wants:

Visibility. Consistency. Scale.

Read the playbook here: https://realtime-eclinical.com/2026/06/16/the-clinical-research-site-playbook-vol-3-everything-sites-need-to-know-about-esource/

When trial opportunities are managed through spreadsheets, email chains, and manual follow-up, it's difficult to maintai...
06/15/2026

When trial opportunities are managed through spreadsheets, email chains, and manual follow-up, it's difficult to maintain visibility, drive engagement, and keep studies moving forward efficiently across a research network.

Our latest case study explores how ๐„๐ฑ๐ข๐ ๐ž๐ง๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก transformed trial opportunity management and site engagement with RealTime-Devana Enterprise.

Previously, leadership had limited visibility into feasibility activity, site interest, and study selection progress, while coordinating opportunities across the network required significant manual effort.

With Devana Enterprise, Exigent gained:

โœ… Centralized visibility into trial opportunities and site engagement
โœ… Automated workflows and follow-up processes that improved coordination at scale
โœ… Real-time reporting and self-service access to operational data for both leadership and participating sites

The result: greater transparency, stronger network engagement, and a more scalable approach to managing study opportunities from initial review through activation.

See how Exigent Research streamlined collaboration and gained real-time operational visibility across its network: https://realtime-eclinical.com/2026/06/15/scaling-oncology-trial-ex*****on-across-exigent-researchs-distributed-network-with-devana-enterprise/

Your coordinators are managing study documentation out of their inboxes. There's a better way.RealTime eDocs has an Outl...
06/12/2026

Your coordinators are managing study documentation out of their inboxes. There's a better way.

RealTime eDocs has an Outlook Add-In that lets your team drag and drop documents and emails directly into your eRegulatory binders, right from where the work is already happening.

No extra steps.
No hunting through folders.
No filing backlogs building up while your coordinators are trying to run visits.

That means less time chasing documents, and more time focused on research.

โ†’ Take a closer look: https://realtime-eclinical.com/solutions/ereg-eisf/

06/11/2026

86% of clinical research leaders say they have real-time visibility into their trial portfolios. 76% are still capturing performance metrics manually or with partial automation. Both of those numbers come from the same survey.

When your team has operated in a manual-reconciliation environment long enough, the workarounds become invisible. The spreadsheet pull feels normal. The status meeting feels necessary. The CTMS export into a separate tracking sheet feels like just how it works.

And most of the time, it does work. Until a sponsor asks an unexpected question, a site goes dark, enrollment misses a milestone, and leadership wants to know why no one saw it coming.

We surveyed clinical research professionals across independent sites, multi-site networks, and large site organizations managing 11+ locations. 43% are running 101+ active studies simultaneously. These are not early-stage operations. These are mature networks facing real complexity.

What they told us about visibility, start-up speed, and performance oversight is worth an honest read.

Download the RealTime Reports: Trial Start-Up, Visibility & Performance Benchmarks Survey right here: https://realtime-eclinical.com/2026/06/05/realtime-reports-trial-start-up-visibility-performance-benchmarks-survey-summary/

RealTime is heading to ๐’๐‹๐„๐„๐ 2026! Weโ€™re excited to join sleep medicine and clinical research professionals at this year...
06/10/2026

RealTime is heading to ๐’๐‹๐„๐„๐ 2026!

Weโ€™re excited to join sleep medicine and clinical research professionals at this yearโ€™s annual meeting to connect, learn, and discuss the evolving landscape of sleep-related clinical trials and research operations.

As studies grow more complex, research teams need technology that simplifies workflows, improves visibility, and helps sites stay focused on ex*****onโ€”not administrative burden. Weโ€™re looking forward to the conversations ahead and sharing how RealTime supports more connected, efficient clinical research.

Attending SLEEP 2026? Letโ€™s connect!

06/09/2026

The biggest threat to trial momentum isnโ€™t always recruitment or protocol complexity; itโ€™s the handoff gap.

Central teams move fast.
Sites get overloaded.
Opportunities stall.
Timelines slip.

When communication and workflows break down between central and site-based teams, study ex*****on suffers.

Thatโ€™s why Devana Enterprise is built to support seamless collaboration across the research lifecycle, helping teams stay aligned, maintain visibility, and keep opportunities moving forward instead of getting lost in the shuffle.

Better coordination means better ex*****on.

Learn more: https://realtime-eclinical.com/solutions/devana/

Most site network CEOs evaluate technology on features. The ones pulling ahead evaluate it on business impact. There's a...
06/08/2026

Most site network CEOs evaluate technology on features. The ones pulling ahead evaluate it on business impact. There's a difference.

And right now, it's showing up in enrollment numbers, margins, and sponsor confidence.

We built the RealTime ROI Calculator so you can see it in your numbers. Your sites, your studies, your products.

Get started right here: https://realtime-eclinical.com/roi-calculator/

๐Ÿ“Š ๐–๐ž ๐ฌ๐ฎ๐ซ๐ฏ๐ž๐ฒ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ'๐ฌ ๐ฅ๐ž๐š๐๐ข๐ง๐  ๐ฌ๐ข๐ญ๐ž ๐ง๐ž๐ญ๐ฐ๐จ๐ซ๐ค ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ ๐จ๐ง ๐ญ๐ซ๐ข๐š๐ฅ ๐ฌ๐ญ๐š๐ซ๐ญ-๐ฎ๐ฉ, ๐ฏ๐ข๐ฌ๐ข๐›๐ข๐ฅ๐ข๐ญ๐ฒ, ๐š๐ง๐ ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐š๐ง๐œ๐ž. ๐‡๐ž๐ซ๐ž'๐ฌ ๐ฐ๐ก๐š๐ญ ๐ฌ๐ž...
06/05/2026

๐Ÿ“Š ๐–๐ž ๐ฌ๐ฎ๐ซ๐ฏ๐ž๐ฒ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ'๐ฌ ๐ฅ๐ž๐š๐๐ข๐ง๐  ๐ฌ๐ข๐ญ๐ž ๐ง๐ž๐ญ๐ฐ๐จ๐ซ๐ค ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ ๐จ๐ง ๐ญ๐ซ๐ข๐š๐ฅ ๐ฌ๐ญ๐š๐ซ๐ญ-๐ฎ๐ฉ, ๐ฏ๐ข๐ฌ๐ข๐›๐ข๐ฅ๐ข๐ญ๐ฒ, ๐š๐ง๐ ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐š๐ง๐œ๐ž. ๐‡๐ž๐ซ๐ž'๐ฌ ๐ฐ๐ก๐š๐ญ ๐ฌ๐ž๐ฉ๐š๐ซ๐š๐ญ๐ž๐ฌ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ž๐ซ๐ฌ.

Most site networks are managing trial oversight the same way they were five years ago.โ€‹

CTMS exports.
Spreadsheets.
Email threads.
Manual reconciliation before every leadership review.โ€‹

The fifth edition of RealTime Reports is now live, bringing together insights from site network and multi-site leaders managing some of the industry's most complex research portfolios.

๐ŸŽฏ๐€ ๐Ÿ๐ž๐ฐ ๐ญ๐ก๐ข๐ง๐ ๐ฌ ๐ญ๐ก๐ž ๐๐š๐ญ๐š ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ž๐:โ€‹

โ†’ 76% are still capturing performance metrics manually or with only partial automation, including the metrics leadership cares most about.โ€‹
โ†’ 52% never share performance dashboards externally with sponsors or CROs.โ€‹

๐“๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ฌ๐ข๐ญ๐ž๐ฌ ๐ฌ๐ก๐š๐ซ๐ž ๐ญ๐ก๐ซ๐ž๐ž ๐ญ๐ซ๐š๐ข๐ญ๐ฌ:

โœ… faster feasibility turnaround
โœ… more automated metric capture
โœ… stronger metrics discipline.

Most networks are falling short on at least two.โ€‹

The full report is available now.โ€‹

๐Ÿ”— Download RealTime Reports: Trial Start-Up, Visibility & Performance Benchmarks Survey Summary here โ†’ https://realtime-eclinical.com/2026/06/05/realtime-reports-trial-start-up-visibility-performance-benchmarks-survey-summary/

Did you know your regulatory docs, source data, and study workflow don't have to live in three different places?Most cli...
06/04/2026

Did you know your regulatory docs, source data, and study workflow don't have to live in three different places?

Most clinical research sites run their regulatory docs in a completely separate platform from their CTMS and eSource. Which means your team is juggling multiple logins, chasing signatures across platforms, and manually reconciling records every time a monitor visits or an audit lands.

We built RealTime eDocs to fix that.

Regulatory documents live inside your CTMS, connected to your source data, with eSignatures and audit trails baked in.

One system. Everything in it.

If you're running clinical trials and still piecing together your regulatory workflow from multiple tools, see what that looks like when it's all in one system โ†’ https://realtime-eclinical.com/solutions/soms-bundled-solutions/

Address

7550 I-10, Suite 800/186
San Antonio, TX
78229

Alerts

Be the first to know and let us send you an email when RealTime posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to RealTime:

Share